mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.2 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
UNC0638 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |